Citation

Wityak J, Prime ME, Brookfield FA, Courtney SM, Erfan S, Johnsen S, Johnson PD, Li M, Marston RW, Reed L, Vaidya D, Schaertl S, Pedret-Dunn A, Beconi M, Macdonald D, Muñoz-Sanjuan I, Dominguez C.: SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease. ACS Med Chem Lett, Volume 3 (12), 2012

Authors

Beconi M, Brookfield FA, Courtney SM, Dominguez C., Erfan S, Johnsen S, Johnson PD, Li M, MacDonald D, Marston RW, Munoz-Sanjuan I, Pedret-Dunn A, Prime ME, Reed L, Schaertl S, Vaidya D, Wityak J

Journal

ACS Med Chem Lett

Year

2012

DOI

10.1021/ml300241m

PubMed

24900424

Machine-readable

REST APIRDF